Drug Type miRNA, AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism SCN9A gene inhibitors(Sodium channel protein type IX alpha subunit gene inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | United States | 23 Apr 2024 |